Servicio de Cardiología, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron (VHIR), Barcelona, CIBER-CV, Spain.
Servicio de Cardiología, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron (VHIR), Barcelona, CIBER-CV, Spain.
Rev Esp Cardiol (Engl Ed). 2021 Mar;74(3):257-262. doi: 10.1016/j.rec.2020.02.015. Epub 2020 Jun 1.
Mortality is high in acute aortic syndrome (AAS), which therefore requires early treatment. This study aimed to analyze changes in the diagnosis and treatment of AAS over 20 years at our center.
From 1999 to 2018, 451 patients diagnosed with AAS (336 men; mean age, 60.9±12.4 years) were prospectively included (270 type A and 181 type B). Clinical variables, diagnosis, treatment, and in-hospital complications were analyzed.
The use of computed tomography (CT) as the first-line diagnostic technique increased from 62.8% to 94.2% (P <.001). Surgical treatment of type A AAS rose from 67.4% to 82.5% (P=.09). Mortality from type A AAS decreased significantly from 53.1% to 26.3% (P <.001) as a result of the fall in mortality from surgical treatment (from 45.4% to 17.0%; P <.001). The use of medical treatment alone for type B AAS decreased from 91.8% to 61.7% (P <.001) due to the greater use of endovascular treatment. Mortality from type B AAS showed no significant reduction (16.2% to 10.6%; P=.15).
The diagnosis and treatment of AAS has changed substantially in the last 2 decades. CT has become the first-line diagnostic technique for AAS. In type A AAS, mortality has fallen significantly due to improvements in the results of surgical treatment. In type B AAS, the use of medical treatment alone has decreased due to the expansion of endovascular treatment, although in-hospital mortality has not decreased significantly.
急性主动脉综合征(AAS)的死亡率很高,因此需要早期治疗。本研究旨在分析 20 年来我院 AAS 的诊断和治疗变化。
1999 年至 2018 年,前瞻性纳入 451 例 AAS 患者(男 336 例;平均年龄 60.9±12.4 岁)(A型 270 例,B 型 181 例)。分析临床变量、诊断、治疗和院内并发症。
作为一线诊断技术的 CT 使用率从 62.8%增加到 94.2%(P<0.001)。A型 AAS 的手术治疗比例从 67.4%上升至 82.5%(P=.09)。A型 AAS 的死亡率显著下降,从 53.1%降至 26.3%(P<0.001),这主要是由于手术治疗死亡率下降(从 45.4%降至 17.0%;P<0.001)。由于腔内治疗的应用增加,B 型 AAS 单纯药物治疗的比例从 91.8%降至 61.7%(P<0.001)。B 型 AAS 的死亡率无显著降低(从 16.2%降至 10.6%;P=.15)。
在过去的 20 年中,AAS 的诊断和治疗发生了重大变化。CT 已成为 AAS 的一线诊断技术。在 A 型 AAS 中,由于手术治疗效果的改善,死亡率显著下降。在 B 型 AAS 中,由于腔内治疗的扩展,单纯药物治疗的应用减少,尽管院内死亡率没有显著降低。